KDIGO Controversies ConferenceWord文档格式.docx

上传人:b****5 文档编号:18838236 上传时间:2023-01-01 格式:DOCX 页数:27 大小:124.07KB
下载 相关 举报
KDIGO Controversies ConferenceWord文档格式.docx_第1页
第1页 / 共27页
KDIGO Controversies ConferenceWord文档格式.docx_第2页
第2页 / 共27页
KDIGO Controversies ConferenceWord文档格式.docx_第3页
第3页 / 共27页
KDIGO Controversies ConferenceWord文档格式.docx_第4页
第4页 / 共27页
KDIGO Controversies ConferenceWord文档格式.docx_第5页
第5页 / 共27页
点击查看更多>>
下载资源
资源描述

KDIGO Controversies ConferenceWord文档格式.docx

《KDIGO Controversies ConferenceWord文档格式.docx》由会员分享,可在线阅读,更多相关《KDIGO Controversies ConferenceWord文档格式.docx(27页珍藏版)》请在冰豆网上搜索。

KDIGO Controversies ConferenceWord文档格式.docx

Chazot,Charles...……….....…………………………………......………………6

Ecder,Tevfik...……….....…………………………………......………………8

Erdem,Yunus..……….....…………………………………………....…………10

Goldsmith,David...……….....…………………..…………………………………12

Lebel,Marcel..……….....………………………………………....……………16

Locatelli,Francesco

(2)..……….....………………………………….......……………18

Naicker,Sarala

(2)………….....……………………………………….....………….21

Suzuki,Hiromichi………….....…………………………………………......………25

Vaziri,N.D.……………………………………………………….......………27

Wizemann,Volker………….....……………………………………………….……30

RajivAgarwal,MD

Indianapolis,USA

BPMEASUREMENT,INTERDIALYTICHYPERTENSIONANDTHEROLEOFSALT

RajivAgarwal,MD,ProfessorofMedicine,IndianaUniversity,Indianapolis,IN,USA

Themanagementofhypertensioninhemodialysispatientsiscomplicatedbydifficultiesinmakinganaccuratediagnosisofhypertensioninthesepatients.Itisnowwellrecognizedthatbloodpressuresobtainedinthedialysisunitbeforeandafterdialysisareinaccurate,impreciseandbiasedestimatesofinterdialyticambulatorybloodpressurerecording1.DialysisunitBPsalsocorrelatepoorlywithleftventricularhypertrophy2.Ontheotherhand,themeanorthemedianofalldialysisunitbloodpressuremeasurementsobtainedduringadialysistreatmentcorrelatebestwithinterdialyticambulatorybloodpressures3.Thus,ifdialysisunitbloodpressuresaretobeusedforclinicaldecisionmaking,itappearsthatitmaybebettertousethemedianintradialyticbloodpressureinsteadofpreorpost-dialysisBP.

Self-measuredhomebloodpressuresobtained2-3timesdailyover4daysafteramid-weekdialysisaremuchbetterinpredictinginterdialyticambulatorybloodpressure,targetorgandamageandall-causemortality4-6.Homebloodpressurerecordingswillcorrectlydiagnosehypretension89%ofthetimewheninterdialyticambulatorybloodpressurerecordingsareusedasthereferencestandard4.Thus,homebloodpressuremonitoringshouldbecomethestandardofcarewhenmanaginghypertensioninhemodialysispatients7.Iadvocatetheuseofbloodpressuresobtainedbeforeandafterdialysistoensurehemodynamicstabilitywhereashomebloodpressuresformanaginghypertensioninhemodialysispatients.Whenusinganautomatic,validated,oscillometricdevice(suchasHEM705CP,OmronHealthCare,Bannockburn,IL),homebloodpressuresaveraging150mmHgormorecarries80%sensitivityand84%specificityindiagnosinghypertension4.

InterdialyticambulatoryBPmonitoringremainsausefultoolbecauseitstronglycorrelateswithmeasuresofarterialstiffnesssuchaspulsewavevelocity8.Increasingpulsewavevelocityisassociatedwithhighermeaninterdialyticambulatorysystolicandbloodpressureaswellashigherpulsepressure.Increasingsodiumintake,andconsequentlyincreasedinterdialyticweightgain,ontheotherhandisassociatedwithgreaterinterdialyticslopesofbloodpressure.

(1)AgarwalR,PeixotoAJ,SantosSF,ZoccaliC.Preandpostdialysisbloodpressuresareimpreciseestimatesofinterdialyticambulatorybloodpressure.ClinJAmSocNephrol2006;

1:

389-98.

(2)AgarwalR,BrimNJ,MahenthiranJ,AndersenMJ,SahaC.Out-of-hemodialysis-unitbloodpressureisasuperiordeterminantofleftventricularhypertrophy.Hypertension2006;

47:

62-8.

(3)AgarwalR,MetikuT,TegegneGG,LightRP,BunayeZ,BekeleDM,KelleyK.DiagnosingHypertensionbyIntradialyticBloodPressureRecordings.ClinJAmSocNephrol2008;

3:

1364-72.

(4)AgarwalR,AndersenMJ,BishuK,SahaC.Homebloodpressuremonitoringimprovesthediagnosisofhypertensioninhemodialysispatients.KidneyInt2006;

69:

900-6.

(5)AgarwalR,AndersenMJ,LightRP.LocationNotQuantityofBloodPressureMeasurementsPredictsMortalityinHemodialysisPatients.AmJNephrol2007;

28:

210-7.

(6)AlborziP,PatelN,AgarwalR.Homebloodpressuresareofgreaterprognosticvaluethanhemodialysisunitrecordings.ClinJAmSocNephrol2007;

2:

1228-34.

(7)AgarwalR.Howshouldhypertensionbeassessedandmanagedinhemodialysispatients?

HomeBP,notdialysisunitBP,shouldbeusedformanaginghypertension.SeminDial2007;

20:

402-5.

(8)AgarwalR,LightRP.Arterialstiffnessandinterdialyticweightgaininfluenceambulatorybloodpressurepatternsinhemodialysispatients.AmJPhysiolRenalPhysiol2007;

294:

F303-F308.

PeterJ.Blankestijn,MD

Utrecht,TheNetherlands

HYPERACTIVITYOFTHERENINANDSYMPATHETICNERVOUSSYSTEMINCKDSTAGEVPATIENTS

PeterJ.Blankestijn,UniversityMedicalCenterUtrecht,theNetherlands

MultiplelinesofevidenceindicatethatvolumeoverloadandenhancedactivitiesofthereninsystemandthesympatheticnervoussystemareimportantindetermininghypertensioninCKDstage5(reviewin1).Epidemiologicalstudiesindialysispatientsshowarelationshipbetweensympatheticactivityandcardiovascularmorbidityandmortality(2,3).Therefore,treatmentshouldbeaimedataddressingthesepathophysiologicalmechanisms.AsaconsequencethecombinationofvolumecorrectionandACEinhibitor/AngIIantagonististhecornerstoneoftreatment.

Severaluncertaintiesexist.

1]ACEi/ARBinusualdosagereducesbutnotnormalisessympatheticactivity(4).Higherthanusualdosagemaybenecessarytoobtainfullvascularprotection.Alternatively,theadditionofanothersympatholyticagenttotheACEi/ARBtreatmentmaybebeneficial.SomedataindeedsuggestthattheadditionofabetablockerorcombiningACEiwithARBmightimproveoutcomeindialysispatients(5).

2]Itisverywellpossiblethattheenhancedactivitiesofthereninandsympatheticsystemdecreaseorceasetoexistinthecourseof“dialysislife”asaresultofprogressivedestructionofkidneytissue.Nodataexistonhowtoidentifypatientswhowillespeciallybenefitofpharmacological(asadditiontovolumecorrection)treatment.

3]Frequentdialysis/highdosagehemodialysislowersympatheticoveractity(6).Themechanism(s)is(are)unknown.Itisnotknownwhetherpatientsonintensivedialysisschedulesbenefitofpharmacologicaltreatment.

Someselectedreferences

1.NeumannJ,LigtenbergG,Klein,II,KoomansHA,BlankestijnPJ.Sympathetichyperactivityinchronickidneydisease:

Pathogenesis,clinicalrelevance,andtreatment.KidneyInt2004;

65:

1568-1576.

2.ZoccaliC,MallamaciF,TripepiG,ParlongoS,CutrupiS,BenedettoFA,etal.Norepinephrineandconcentrichypertrophyinpatientswithend-stagerenaldisease.Hypertension2002;

40:

41-6.

3.ZoccaliC,MallamaciF,ParlongoS,CutrupiS,BenedettoFA,TripepiG,etal.Plasmanorepinephrinepredictssurvivalandincidentcardiovasculareventsinpatientswithend-stagerenaldisease.Circulation2002;

105:

1354-9.

4.NeumannJ,LigtenbergG,KleinIH,BoerP,OeyPL,KoomansHA,BlankestijnPJ.Sympathetichyperactivityinhypertensivechronickidneydiseasepatientsisreducedduringstandardtreatment.Hypertension2007;

49:

506-510.

5.CiceG,FerraraL,D'

AndreaA,D'

IsaS,DiBenedettoA,CittadiniA,etal.Carvedilolincreasestwo-yearsurvivalindialysispatientswithdilatedcardiomyopathy:

aprospective,placebo-controlledtrial.JAmCollCardiol2003;

41:

1438-44.

6.ZilchO,VosPF,OeyPL,CramerMJ,LigtenbergG,KoomansHA,BlankestijnPJ.Sympathetichyperactivityinhaemodialysispatientsisreducedbyshortdailyhaemodialysis.JHypertens2007;

25:

1285-1289.

CharlesChazot,MD

Tassin-la-Demi-Lune,France

THELAG-PHENOMENONOFHYPERTENSIONCORRECTIONINHEMODIALYSISPATIENTS:

AREAPPRAISAL

CharlesChazot,MD,Tassin-la-Demi-Lune,France

Thelagphenomenonisthedelaythatisobservedbetweenthereachofdryweightandtheplateauofnormalpredialysisbloodpressure1,2.Ithasbeenreportedinincidenthemodialysis(HD)patientsreceiving8-hourdialysis3timesaweekandinwhichthedryweightmethodwasapplied3.Thisphenomenonisalsodescribedwiththiazidetherapyinhypertensivepatients4.Oneofthestronghypothesestounderstandthesefindingsisthatthelagphenomenonisrelatedtothecorrectionofthecardiovascularremodelingassociatedwiththeextracellularvolume(ECV)overload5.Guyton’sexperimentinnephrectomizeddogsfedwithsaltyfoodhasshownthatafter2weekstheanimalspresentwithsustainedhypertensionandincreasedperipheralresistances6.PeripheralresistancesareoftenreportedincreasedinhypertensiveHDpatients7-9,whereastheywerefoundlowinTassinnormotensivepatients8UncontrolledstudieshaveshownanimprovementofcardiovascularremodelingbystrictvolumecontrolinHDpatients10,11.Themechanismsofvascularremodelinghavebeenrecentlyreviewed5includingtheroleofECVexpansiononouabaï

n-likecompoundsactingasNa-K-ATPaseinhibitors,theroleofhighsodiumintakeonnitricoxideimbalanceandalteredendothelialmetabolism.Inconclusion,theexistenceofthislagphenomenoninHDpatientsstressestheimportanceofthephysiopathologyofsodiumimbalanceandECVoverloadindialysispatients.IthighlightsthefactthatsustainedcorrectionofhypertensionismorethanshorttermECVcorrection.Isaprolongednegativesodiumbalancetheanswer?

NewtoolsareneededtofollownotonlytheECVbutalsothehemodynamicconsequencesofitsexpansion.

1.CharraB,BergstromJ,ScribnerBH.Bloodpressurecontrolindialysispatients:

importanceofthelagphenomenon.AmJKidneyDis1998;

32(5):

720-4.

2.ChazotC,CharraB,VoVanC,etal.TheJanus-facedaspec

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 医药卫生 > 基础医学

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1